CAS 5786-21-0
:Clozapina
- 5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-
- 8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine
- 8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine
- Apo-Clozapine
- Asaleptin
- Azaleptin
- Azaleptine
- Brn 0764984
- Ccris 9171
- Clorazil
- Cloril
- Clozapex
- Clozapin
- Clozapina
- Clozapina [INN-Spanish]
- Clozapinum
- Clozapinum [INN-Latin]
- Clozaril
- Fazaclo
- Fazaclo ODT
- Hf-1854
- Hsdb 6478
- Iprox
- Klozapol
- Leponex
- Lx 100-129
- Sizopin
- Unii-J60Ar2Ikic
- W-801
- Clozapine
- e)(1,4)diazepine,8-chloro-11-(4-methyl-1-piperazinyl)-5h-dibenzo(
- CLOZAPINE ATYPICAL NEUROLEPTIC
- LIPONEX
- Lepotex
- COLZARIL
- 8-chloro-11-(4-methyl-1-piperazinyl)-5h-dibenzo(e)(1,4)diazepine
- Vedi altri sinonimi
Ref: ST-EA-CP-C63000
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiestaClozapine
CAS:Prodotto controllatoApplications An antipsychotic.
Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package
References Stille, et al: Farnaco, Ed. Prat., 26, 603 (1971), Hane, J.M., et al.: Psychopharmacol. Bull., 24, 62 (1988), Meltzer, H.Y.: J. Clin. Psychiatry, 55, Suppl. B, 47 (1994)Formula:C18H19ClN4Colore e forma:NeatPeso molecolare:326.82Clozapine
CAS:Prodotto controllatoPartial 5-HT1A agonist; adrenergic, cholinergic, and histaminergic antagonistFormula:C18H19ClN4Purezza:Min. 97.5 Area-%Colore e forma:Yellow PowderPeso molecolare:326.82 g/molClozapine - Bio-X ™
CAS:Prodotto controllatoClozapine, a dibenzodiazepine, demonstrates antagonistic activity at the dopamine receptors, further binding to serotonin (5-HT1A, 5-HT2A-C, 5-HT6, 5-HT7), alpha 1 and 2 adrenergic, histamine 1 and M1-M5 muscarinic receptors. In particular, its partial 5-HT1A agonist behaviour, its low affinity for the D2 Dopamine receptors and its antagonistic activity at 5-HT2A receptors, are properties, which make it useful as an antipsychotic drug. The FDA has approved Clozapine for use in the alleviation of symptoms in treatment-resistant schizophrenia patients, such as the risk of self-harm. Although not yet approved by the FDA, Clozapione exerts positive effects in Parkinson’s disease and bipolar disorder treatments. However, Clozapione is not currently a first line-therapy option, as it may cause agranulocytosis and other side effects such as orthostatic hypotension and hypersalivation.
Formula:C18H19ClN4Purezza:Min. 95%Colore e forma:Yellow PowderPeso molecolare:326.82 g/mol5-Acetyl-8-chloro-5H-dibenzo[b,e][1,4]diazepin-11(10H)-one
CAS:Formula:C15H11ClN2O2Colore e forma:NeatPeso molecolare:286.713



